Eintrag weiter verarbeiten

798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a...

Gespeichert in:

Veröffentlicht in: Blood 124(2014,21) Artikel-Nr. 76104, 1 S.
Personen und Körperschaften: Ottmann, Oliver G. (Sonstige), Heidenreich, Daniela (Sonstige)
Titel: 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a trial of the European Working Group for Adult ALL (EWALL-PH-02)/ Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot
Format: E-Book-Kapitel Konferenzbericht
Sprache: Englisch
veröffentlicht:
2014
Gesamtaufnahme: : Blood, 124(2014,21) Artikel-Nr. 76104, 1 S.
, volume:124
Schlagwörter:
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
LEADER 02471caa a2200445 4500
001 0-1505167191
003 DE-627
005 20220812013848.0
007 cr uuu---uuuuu
008 150707s2014 xx |||||o 00| ||eng c
035 |a (DE-627)1505167191 
035 |a (DE-576)435167197 
035 |a (DE-599)BSZ435167197 
035 |a (OCoLC)1340701186 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
245 1 0 |a 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL)  |b a trial of the European Working Group for Adult ALL (EWALL-PH-02)  |c Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot 
264 1 |c 2014 
300 |a 1 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.07.2015 
655 7 |a Konferenzschrift  |0 (DE-588)1071861417  |0 (DE-627)826484824  |0 (DE-576)433375485  |2 gnd-content 
700 1 |a Ottmann, Oliver G.  |0 (DE-588)1073558401  |0 (DE-627)829169059  |0 (DE-576)435167081  |4 oth 
700 1 |a Heidenreich, Daniela  |d 1976-  |0 (DE-588)124462073  |0 (DE-627)36336479X  |0 (DE-576)294183248  |4 oth 
773 0 8 |i In  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 124(2014,21) Artikel-Nr. 76104, 1 S.  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnns 
773 1 8 |g volume:124  |g year:2014  |g number:21  |g extent:1 
856 4 0 |u https://ash.confex.com/ash/2014/webprogram/Paper76104.html  |x Verlag  |z kostenfrei  |3 Volltext 
936 u w |d 124  |j 2014  |e 21  |g 1  |y 124(2014,21) Artikel-Nr. 76104, 1 S. 
951 |a AR 
856 4 0 |u https://ash.confex.com/ash/2014/webprogram/Paper76104.html  |9 LFER 
852 |a LFER  |z 2017-09-14T00:00:00Z 
970 |c OD 
971 |c EBOOK 
972 |c EBOOK 
973 |c Aufsatz 
935 |a lfer 
900 |a Heidenreich, Daniela Brigitte 
980 |a 1505167191  |b 0  |k 1505167191  |o 435167197  |c lfer 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=798+Nilotinib+%28Tasigna%C2%AE%29+and+chemotherapy+for+first-line+treatment+in+elderly+patients+with+De+Novo+Philadelphia+Chromosome%2FBCR-ABL1+positive+acute+lymphoblastic+leukemia+%28ALL%29%3A+a+trial+of+the+European+Working+Group+for+Adult+ALL+%28EWALL-PH-02%29&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1528-0020
SOLR
_version_ 1757940162735636480
access_facet Electronic Resources
author2 Ottmann, Oliver G., Heidenreich, Daniela
author2_role oth, oth
author2_variant o g o og ogo, d h dh
author_facet Ottmann, Oliver G., Heidenreich, Daniela
callnumber-sort
collection lfer
container_reference 124(2014,21) Artikel-Nr. 76104, 1 S.
container_title Blood
ctrlnum (DE-627)1505167191, (DE-576)435167197, (DE-599)BSZ435167197, (OCoLC)1340701186
facet_avail Online, Free
finc_class_facet not assigned
finc_id_str 0019909994
footnote Gesehen am 07.07.2015
format ElectronicBookComponentPart, ConferenceProceedings
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-monograph-child-conference
format_dezi4 e-Book
format_finc Article, E-Article
format_legacy ElectronicBookPart
genre Konferenzschrift (DE-588)1071861417 (DE-627)826484824 (DE-576)433375485 gnd-content
genre_facet Konferenzschrift
geogr_code not assigned
geogr_code_person not assigned
hierarchy_parent_id 0-266886647
hierarchy_parent_title Blood
hierarchy_sequence 124(2014,21) Artikel-Nr. 76104, 1 S.
hierarchy_top_id 0-266886647
hierarchy_top_title Blood
id 0-1505167191
illustrated Not Illustrated
imprint 2014
imprint_str_mv 2014
institution DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2
is_hierarchy_id 0-1505167191
is_hierarchy_title 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a trial of the European Working Group for Adult ALL (EWALL-PH-02)
isil_str_mv LFER
issn 1528-0020
kxp_id_str 1505167191
language English
last_indexed 2023-02-15T23:06:22.927Z
match_str ottmann2014798nilotinibtasignarandchemotherapyforfirstlinetreatmentinelderlypatientswithdenovophiladelphiachromosomebcrabl1positiveacutelymphoblasticleukemiaallatrialoftheeuropeanworkinggroupforadultallewallph02
mega_collection Verbunddaten SWB, Lizenzfreie Online-Ressourcen
misc_de105 EBOOK
multipart_link 075961938
multipart_part (075961938)124(2014,21) Artikel-Nr. 76104, 1 S.
names_id_str_mv (DE-588)1073558401, (DE-627)829169059, (DE-576)435167081, (DE-588)124462073, (DE-627)36336479X, (DE-576)294183248
oclc_num 1340701186
physical 1
publishDate 2014
publishDateSort 2014
publishPlace
publisher
record_format marcfinc
record_id 435167197
recordtype marcfinc
rvk_facet No subject assigned
source_id 0
spelling 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL) a trial of the European Working Group for Adult ALL (EWALL-PH-02) Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot, 2014, 1, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 07.07.2015, Konferenzschrift (DE-588)1071861417 (DE-627)826484824 (DE-576)433375485 gnd-content, Ottmann, Oliver G. (DE-588)1073558401 (DE-627)829169059 (DE-576)435167081 oth, Heidenreich, Daniela 1976- (DE-588)124462073 (DE-627)36336479X (DE-576)294183248 oth, In Blood Washington, DC : American Society of Hematology, 1946 124(2014,21) Artikel-Nr. 76104, 1 S. Online-Ressource (DE-627)266886647 (DE-600)1468538-3 (DE-576)075961938 1528-0020 nnns, volume:124 year:2014 number:21 extent:1, https://ash.confex.com/ash/2014/webprogram/Paper76104.html Verlag kostenfrei Volltext, https://ash.confex.com/ash/2014/webprogram/Paper76104.html LFER, LFER 2017-09-14T00:00:00Z
spellingShingle 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a trial of the European Working Group for Adult ALL (EWALL-PH-02), Konferenzschrift
swb_id_str 435167197
title 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a trial of the European Working Group for Adult ALL (EWALL-PH-02)
title_auth 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL) a trial of the European Working Group for Adult ALL (EWALL-PH-02)
title_full 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL) a trial of the European Working Group for Adult ALL (EWALL-PH-02) Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot
title_fullStr 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL) a trial of the European Working Group for Adult ALL (EWALL-PH-02) Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot
title_full_unstemmed 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL) a trial of the European Working Group for Adult ALL (EWALL-PH-02) Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot
title_in_hierarchy 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a trial of the European Working Group for Adult ALL (EWALL-PH-02) / Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot,
title_short 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL)
title_sort 798 nilotinib tasigna® and chemotherapy for first line treatment in elderly patients with de novo philadelphia chromosome bcr abl1 positive acute lymphoblastic leukemia all a trial of the european working group for adult all ewall ph 02
title_sub a trial of the European Working Group for Adult ALL (EWALL-PH-02)
topic Konferenzschrift
topic_facet Konferenzschrift
url https://ash.confex.com/ash/2014/webprogram/Paper76104.html